soul trial oral semaglutide cardiovascular outcomes 2024 results nejm Editorial Fellow Harleen Marwah, MD, summarizes the trial. Read the full at NEJM.org (link in bio). ⁣ ⁣ #ACC25 #Cardiology #ClinicalTrials #NEJM soul trial oral semaglutide cardiovascular

Call or stop by your nearest SynergenX location, whether in Houston, Dallas, San Antonio or Chicago, and ask about adding a B12 injection to your plan

In early 2019 Novo Nordisk filed with the US FDA to obtain approval for an oral version (Rybelsus) of its injectable drug semaglutide (Ozempic) and it was approved in September of 2019

Ozempic is not just a celebrity buzzword

GENTLE FOR ALL SKIN TYPES: Formulated with gentle ingredients suitable for all skin types, this versatile serum fits seamlessly into daily skincare routines and works well as a pre-makeup treatment

However, value-based care systems such as Kaiser Permanentes encourage and facilitate sustained holistic support over the long term

For menopausal women who cannot or prefer not to use GLP-1 agonists, AOD-9604 offers an alternative mechanism that targets fat cells directly